2011, Number 1
<< Back Next >>
Rev Invest Clin 2011; 63 (1)
Chronic anemia as a manifestation of MELAS syndrome
Finsterer J
Language: English
References: 12
Page: 100-103
PDF size: 35.68 Kb.
Text Extraction
INTRODUCTION
Myopathy, encephalopathy, lactacidosis and
stroke-like episodes (MELAS)-syndrome is a heterogeneous
respiratory-chain-disorder (RCD) due to
point mutations in mitochondrial genes (m.583G›A,
m.1642G›A, m.3243A›G, m.3252A›G, m.3260A
›G, m.3271T›C, m.3291T›C, m.5814A›G,
m.9957T›C, m.13513G›A), due to mtDNA deletions,
or due to nDNA mutations, such as in POLG1. Like
most of the RCDs, MELAS is a multi-system disease,
involving the brain, peripheral nervous-system, eyes,
endocrine glands, heart, guts, kidney, or dermis.2
Involvement of the bone marrow, manifesting as
hy- pochrome, and microcytic anemia, has been only
occasionally described.
REFERENCES
Zeviani M. Mitochondrial disorders. Suppl Clin Neurophysiol 2004; 57: 304-12.
Zaffanello M, Zamboni G. Therapeutic approach in a case of Pearson’s syndrome. Minerva Pediatr 2005; 57: 143-6.
Inbal A, Avissar N, Shaklai M, Kuritzky A, Schejter A, Ben-David E, Shanske S, Garty BZ. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet 1995; 55: 372-8.
Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K. The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 1997; 20: 697-703.
Reichenbach J, Schubert R, Horvŕth R, Petersen J, Fütterer N, Malle E, Stumpf A, et al. Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency. Pediatr Res 2006; 60: 321-6.
Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter JC, de la Red G, Gil V, et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730-6.
Finsterer J. MELAS syndrome as a differential diagnosis of ischemic stroke. Fortschr Neurol Psychiatr 2009; 77: 25-31.
Finsterer J. Hematological manifestations of primary mitochondrial disorders. Acta Haematol 2007; 118: 88-98.
Thomas C, Thomas L. Anemia of chronic disease: patho physiology and laboratory diagnosis. Lab Hematol 2005; 11: 14-23.
Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004; 74: 1303-8.
Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005; 44: 1025-6.
Rubio-Gozalbo ME, Sengers RC, Trijbels JM, Doesburg WH, Janssen AJ, Verbeek AL, Smeitink JA. A prognostic index as diagnostic strategy in children suspected of mitochondriocytopathy. Neuropediatrics 2000; 31: 114-21.